血液科
血小板減少症的管理
Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors. （開啟新視窗）
來源: Platelets. 2022 3;33(7):1024-1030.
檢索: PubMed 35040375
DOI碼: 10.1080/09537104.2022.2026910
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. （開啟新視窗）
來源: Lancet Haematol 2018;5(3):e117-e126.
檢索: PubMed 29396092
DOI碼: 10.1016/S2352-3026(18)30016-4